[Stability of Insulin in Total Parenteral Nutrition Solutions].


Journal

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
ISSN: 1347-5231
Titre abrégé: Yakugaku Zasshi
Pays: Japan
ID NLM: 0413613

Informations de publication

Date de publication:
2020
Historique:
entrez: 3 4 2020
pubmed: 3 4 2020
medline: 8 9 2020
Statut: ppublish

Résumé

Elneopa NF No. 1 and No. 2 infusions are complete parenteral nutrition solutions packaged as four-chambered bags. They have been used for home parenteral nutrition, with insulin injected into the bags for patients whose blood glucose becomes elevated. In this study, the stability of insulin in No. 1 and No. 2 bags was investigated. The quantity of insulin in Elneopa NF No. 2 was significantly lower than that in Elneopa NF No. 1. When insulin was injected into the upper chamber of either product, decreases in insulin levels were not observed. In contrast, the levels of insulin injected into the lower chamber of both products significantly decreased, with a larger difference in Elneopa NF No. 2. As the amino acid content is different between No. 1 and No. 2, amino acids may be considered a potential cause for the degradation of insulin in the bags. In addition, decreases in insulin levels were observed as the solutions passed through infusion sets just after flushing began, with both Elneopa NF No. 1 and No. 2. In conclusion, the concentration of insulin injected into the Elneopa infusion bags decreases, especially in No. 2 bags, and insulin is absorbed by the infusion sets.

Identifiants

pubmed: 32238640
doi: 10.1248/yakushi.19-00251
doi:

Substances chimiques

Insulin 0
Solutions 0

Types de publication

Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

577-584

Auteurs

Takefumi Kumagai (T)

Pharmacy Co. Ltd.

Yoshitaka Kihira (Y)

Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.

Yoshino Fujimura (Y)

Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.

Ken Miyago (K)

Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.

Chiaki Katayama (C)

Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.

Nozomu Matsutani (N)

Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.

Hirofumi Inoue (H)

Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.

Yasuto Tsuruta (Y)

Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.

Hironori Yoshitomi (H)

Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.

Eiji Sato (E)

Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University.

Articles similaires

Humans Insulin Resistance Muscle, Skeletal Oxidative Stress Oxidation-Reduction
1.00
Humans Paper Contraceptives, Oral Carbon Dioxide Female
Animals Extracellular Vesicles Adipocytes Swine Adipogenesis
Humans Diabetes Mellitus, Type 1 Hypoglycemia Patient Education as Topic Randomized Controlled Trials as Topic

Classifications MeSH